Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0PRKPN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
VL-DAB31-SN38
|
|||||
| Synonyms |
VL DAB31 SN38
Click to Show/Hide
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
B-cell lymphoma [ICD11:2A86]
Investigative
|
|||||
| Structure |
|
|||||
| Antibody Name |
Rabbit derived VL single-domain Anti-ody
|
Antibody Info | Antigen Name |
Undisclosed
|
||
| Payload Name |
Active metabolite of irinotecan SN38
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Mal-Cyc-PEG3-DAB
|
Linker Info | ||||
| Conjugate Type |
Site-specific conjugating to the free sulfhydryl group of cysteine 82 on the VL single-domain antibody, Michael addition reaction.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.